The International Consensus Classification (ICC) of hematologic neoplasms with germline predisposition, pediatric myelodysplastic syndrome, and juvenile myelomonocytic leukemia-Reference-Cited by-同舟云学术

The International Consensus Classification (ICC) of hematologic neoplasms with germline predisposition, pediatric myelodysplastic syndrome, and juvenile myelomonocytic leukemia

Published:2022-11-29 Issue:1 Volume:482 Page:113-130
ISSN:0945-6317
Container-title:Virchows Archiv
language:en
Short-container-title:Virchows Arch

Author:

Rudelius Martina,Weinberg Olga K.,Niemeyer Charlotte M.,Shimamura Akiko,Calvo Katherine R.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology,General Medicine,Pathology and Forensic Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00428-022-03447-9.pdf

Reference123 articles.

1. Arber DA, Orazi A, Hasserjian RP et al (2022) International Consensus Classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data. Blood 140(11):1200–1228

2. Kobayashi S, Kobayashi A, Osawa Y et al (2017) Donor cell leukemia arising from preleukemic clones with a novel germline DDX41 mutation after allogenic hematopoietic stem cell transplantation. Leukemia 31(4):1020–1022

3. Galera P, Hsu AP, Wang W et al (2018) Donor-derived MDS/AML in families with germline GATA2 mutation. Blood 132(18):1994–1998

4. Xiao H, Shi J, Luo Y et al (2011) First report of multiple CEBPA mutations contributing to donor origin of leukemia relapse after allogeneic hematopoietic stem cell transplantation. Blood 117(19):5257–5260

5. Owen CJ, Toze CL, Koochin A et al (2008) Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy. Blood 112(12):4639–4645

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Importance of genetic clarification in cytopenia syndromes (childhood myelodysplastic syndrome forms);memo - Magazine of European Medical Oncology;2024-08-29

2. Peripheral Blood and Bone Marrow Findings in Treatment-Naive Patients With Cytopenia(s)/Myeloid Neoplasms Harboring Both a Germline and a Somatic DDX41 Mutation;Applied Immunohistochemistry & Molecular Morphology;2024-07-24

3. Venetoclax: a new player in the treatment of children with high-risk myeloid malignancies?;Blood Advances;2024-07-09

4. The different faces of GATA2 deficiency: implications for therapy and surveillance;Frontiers in Oncology;2024-06-27

5. Germline Predisposition to Hematopoietic Malignancies: An Overview;Annual Review of Cancer Biology;2024-06-12